DEVELOPMENT AND EVALUATION OF A POLOXAMER- AND CHITOSAN-BASED IN SITU GEL-FORMING INJECTABLE DEPOT
Objective: The present study is intended to investigate the applicability of poloxamer- and chitosan-based temperature induced in situ injectable gelling depot for once a week therapy as an intramuscular injection employing olanzapine as a model drug.
Methods: The thermosetting gel was prepared by admixture of a solution of poloxamer P127 and a solution of olanzapine and chitosan in aqueous acetic acid. The resultant formulation was characterized for gelation temperature, gelation time, viscosity, syringeability, pH, drug content, and in vitro drug release. The in vitro release of olanzapine from the gelled depot was followed using USP paddle type II apparatus in conjunction with a dialysis bag. The gel was injected ex vivo into chicken muscle and observed by subsequent dissection.
Results: The formulation was designed to have a phase transition temperature of 34°C and gelled in <10 s at 37°C. Addition of chitosan imparted favorable rheological properties to the poloxamer gel and resulted in a pseudoplastic mixture with low viscosity in the sol state and higher viscosity post gelation. The preparation had a pH of 5.4, appropriate drug content and readily passed through a 20 gauge needle. The release of olanzapine was unhindered by the dialysis bag. Following an initial bust, a sustained, zero-order release of the remainder of drug was observed up to 9 days. The injectable was found to form a compact depot when evaluated ex vivo.
Conclusion: The developed system showed several features which make it a suitable vehicle for sustained intramuscular delivery of drugs.
2. Zhang K, Shi X, Lin X, Yao C, Shen L, Feng Y. Poloxamer-based in situ hydrogels for controlled delivery of hydrophilic macromolecules after intramuscular injection in rats. Drug Deliv 2015;22:375-82.
3. Sindhu SK, Gowda DV, Vishnu Datta S. Formulation and evaluation of injectable in situ gelling matrix system for controlled drug release. Indian J Adv Chem Sci 2014;2:89-92.
4. Johnston TP, Miller SC. Toxicological evaluation of poloxamer vehicles for intramuscular use. J Parenter Sci Technol 1985;39:83-9.
5. Gratieri T, Gelfuso GM, Rocha EM, Sarmento VH, de Freitas O, Lopez RF. A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. Eur J Pharm Biopharm 2010;75:186-93.
6. Varshosaz J, Tabbakhian M, Salmani Z. Designing of a thermosensitive chitosan/poloxamer in situ gel for ocular delivery of ciprofloxacin. Open Drug Deliv J 2008;2:61-70.
7. Irimia T, Dinu-Pîrvu CE, Ghica MV, Lupuleasa D, Muntean DL, Udeanu DI, et al. Chitosan-based in situ gels for ocular delivery of therapeutics: A state-of-the-art review. Mar Drugs 2018;16:373.
8. Chokhawala K, Stevens L. Antipsychotic Medications. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2019.
9. Nielsen MK, Johansen SS. Determination of olanzapine in whole blood using simple protein precipitation and liquid chromatography-tandem mass spectrometry. J Anal Toxicol 2009;33:212-7.
10. Chandra GS. The Preparation and Characterization of Poloxamer-based Temperature-Sensitive Hydrogels for Topical Drug Delivery, Doctoral Dissertation. United States: University of Toledo; 2013.
11. Hemelryck SV, Dewulf J, Niekus H, van Heerden M, Ingelse B, Holm R, et al. In vitro evaluation of poloxamer in situ forming gels for bedaquiline fumarate salt and pharmacokinetics following intramuscular injection in rats. Int J Pharm X 2019;1:100016.
12. Escobar-Chávez JJ, López-Cervantes M, Naïk A, Kalia YN, Quintanar-Guerrero D, Ganem-Quintanar A. Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci 2006;9:339-58.
13. Rassing JR. Hydrogen bonding in acetic acid/acetone mixtures. J Chem Phys 1972;56:5225-8.
14. Napaporn J, Thomas M, Svetic KA, Shahrokh Z, Brazeau GA. Assessment of the myotoxicity of pharmaceutical buffers using an in vitro muscle model: Effect of pH, capacity, tonicity, and buffer type. Pharm Dev Technol 2000;5:123-30.
15. Tirnaksiz F, Robinson JR. Rheological, mucoadhesive and release properties of pluronic F-127 gel and pluronic F-127/polycarbophil mixed gel systems. Pharmazie 2005;60:518-23.
16. Tu?cu-Demiröz F. Development of in situ poloxamer-chitosan hydrogels for vaginal drug delivery of benzydamine hydrochloride: Textural, mucoadhesive and in vitro release properties. Marmara Pharm J 2017;21:762-70.
17. Ur-Rehman T, Tavelin S, Gröbner G. Chitosan in situ gelation for improved drug loading and retention in poloxamer 407 gels. Int J Pharm 2011;409:19-29.
18. Giuliano E, Paolino D, Fresta M, Cosco D. Mucosal applications of poloxamer 407-based hydrogels: An overview. Pharmaceutics 2018;10:159.
19. Ricci EJ, Bentley MV, Farah M, Bretas RE, Marchetti JM. Rheological characterization of poloxamer 407 lidocaine hydrochloride gels. Eur J Pharm Sci 2002;17:161-7.
20. Xuan JJ, Balakrishnan P, Oh DH, Yeo WH, Park SM, Yong CS, et al. Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam. Int J Pharm 2010;395:317-23.
21. Lindenmayer JP. Long-acting injectable antipsychotics: Focus on olanzapine pamoate. Neuropsychiatr Dis Treat 2010;6:261-7.
22. Andhariya JV, Jog R, Shen J, Choi S, Wang Y, Zou Y, et al. Development of level a in vitro in vivo correlations for peptide loaded PLGA microspheres. J Controll Release 2019;308:1-3.
23. Heres S, Kraemer S, Bergstrom RF, Detke HC. Pharmacokinetics of olanzapine long-acting injection: The clinical perspective. Int Clin Psychopharmacol 2014;29:299-312.
24. Yu Z, Li H, Xiong Y, Guo F, Zhang Z. Pharmacokinetic studies of an in situ forming gel system for controlled delivery of enrofloxacin in pigs. SOJ Pharm Pharm Sci 2018;5:1-5.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.